Business Description
ISIN : US0576652004
Share Class Description:
BCPC: Ordinary SharesTotal Employee Number:
1,379Financial Strength
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Cash-To-Debt | 0.41 | |||||
Equity-to-Asset | 0.77 | |||||
Debt-to-Equity | 0.12 | |||||
Debt-to-EBITDA | 0.58 | |||||
Interest Coverage | 24.44 | |||||
Piotroski F-Score | 9/9 | |||||
Altman Z-Score | 11.09 | |||||
Beneish M-Score | -2.53 | |||||
WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | 3 | |||||
3-Year EBITDA Growth Rate | 8.9 | |||||
3-Year EPS without NRI Growth Rate | 8.5 | |||||
3-Year FCF Growth Rate | 24.7 | |||||
3-Year Book Growth Rate | 10.4 | |||||
Future 3-5Y EPS without NRI Growth Rate Estimate Industry Rank | 11.22 | |||||
Future 3-5Y Total Revenue Growth Rate Estimate | 6.59 |
Momentum Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
5-Day RSI | 43.55 | |||||
9-Day RSI | 51.96 | |||||
14-Day RSI | 55.64 | |||||
3-1 Month Momentum % | 2.4 | |||||
6-1 Month Momentum % | -9.17 | |||||
12-1 Month Momentum % | 0.97 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Current Ratio | 2.66 | |||||
Quick Ratio | 1.56 | |||||
Cash Ratio | 0.43 | |||||
Days Inventory | 76.01 | |||||
Days Sales Outstanding | 48.02 | |||||
Days Payable | 33.39 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Dividend Yield % | 0.55 | |||||
Dividend Payout Ratio | 0.18 | |||||
3-Year Dividend Growth Rate | 10.6 | |||||
Forward Dividend Yield % | 0.55 | |||||
5-Year Yield-on-Cost % | 0.91 | |||||
3-Year Average Share Buyback Ratio | 0.1 | |||||
Shareholder Yield % | 3.37 |
Profitability Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Gross Margin % | 36.3 | |||||
Operating Margin % | 20.42 | |||||
Net Margin % | 15.14 | |||||
EBITDA Margin % | 24.81 | |||||
FCF Margin % | 15.78 | |||||
OCF Margin % | 20.22 | |||||
ROE % | 12.82 | |||||
ROA % | 9.78 | |||||
ROIC % | 11.53 | |||||
3-Year ROIIC % | 169.88 | |||||
ROC (Joel Greenblatt) % | 46.67 | |||||
ROCE % | 14.44 | |||||
Years of Profitability over Past 10-Year | 10 | |||||
Moat Score | 6 | |||||
Tariff Resilience Score | 6 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
PE Ratio | 35.08 | |||||
Forward PE Ratio | 30.61 | |||||
PE Ratio without NRI | 32.58 | |||||
Shiller PE Ratio | 47.49 | |||||
Price-to-Owner-Earnings | 35.17 | |||||
PEG Ratio | 3.47 | |||||
PS Ratio | 5.31 | |||||
PB Ratio | 4.38 | |||||
Price-to-Tangible-Book | 16.69 | |||||
Price-to-Free-Cash-Flow | 33.71 | |||||
Price-to-Operating-Cash-Flow | 26.31 | |||||
EV-to-EBIT | 26.17 | |||||
EV-to-Forward-EBIT | 27.5 | |||||
EV-to-EBITDA | 21.51 | |||||
EV-to-Forward-EBITDA | 20.3 | |||||
EV-to-Revenue | 5.34 | |||||
EV-to-Forward-Revenue | 5.07 | |||||
EV-to-FCF | 33.82 | |||||
Price-to-GF-Value | 0.98 | |||||
Price-to-Projected-FCF | 2.15 | |||||
Price-to-DCF (Earnings Based) | 2.2 | |||||
Price-to-DCF (FCF Based) | 2.34 | |||||
Price-to-Median-PS-Value | 1.06 | |||||
Price-to-Peter-Lynch-Fair-Value | 3.51 | |||||
Price-to-Graham-Number | 4.92 | |||||
| Price-to-Net-Current-Asset-Value | 1487.92 | |||||
Earnings Yield (Greenblatt) % | 3.82 | |||||
FCF Yield % | 3.01 | |||||
Forward Rate of Return (Yacktman) % | 11.64 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with NAS:BCPC
Peter Lynch Chart
Performance
Annualized Return % Â
Total Annual Return % Â
Balchem Corp Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil $) | 1,085.881 | ||
| EPS (TTM) ($) | 5.09 | ||
| Beta | 0.7519 | ||
| 3-Year Sharpe Ratio | 0.24 | ||
| 3-Year Sortino Ratio | 0.4 | ||
| Volatility % | 20.71 | ||
| 14-Day RSI | 55.64 | ||
| 14-Day ATR ($) | 3.885784 | ||
| 20-Day SMA ($) | 177.86375 | ||
| 12-1 Month Momentum % | 0.97 | ||
| 52-Week Range ($) | 139.17 - 183.9 | ||
| Shares Outstanding (Mil) | 31.88 |
Piotroski F-Score Details
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 9 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Balchem Corp Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Balchem Corp Stock Events
| Event | Date | Price ($) | ||
|---|---|---|---|---|
| Fourth quarter earnings conference call for 2026 | 2027-02-19 11:00 | In 176 days | ||
| Annual report for 2026 | 2027-02-19 | In 175 days | ||
| Fourth quarter earnings results for 2026 | 2027-02-19 | In 175 days | ||
| Third quarter earnings conference call for 2026 | 2026-10-21 11:00 | In 55 days | ||
| Third quarter earnings results for 2026 | 2026-10-21 | In 54 days | ||
| Second quarter earnings conference call for 2026 | 2026-07-31 11:00 | 162.73 (-0.36%) | ||
| Second quarter earnings results for 2026 | 2026-07-31 | 162.73 (-0.36%) | ||
| General meeting for 2026 | 2026-06-18 08:30 | 164.38 (+0.42%) | ||
| Wells Fargo Industrials Conference | 2026-06-10 | 162.32 (+1.51%) | ||
| First quarter earnings conference call for 2026 | 2026-04-30 11:00 | 173.33 (-1.42%) |
Balchem Corp Frequently Asked Questions
Guru Commentaries on NAS:BCPC
Balchem Corp. (BCPC) develops specialty ingredients for the nutrition, food, and healthcare markets. The stock underperformed despite another quarter of solid financial results as investors focused on the potential for higher costs associated with ongoing macroeconomic uncertainty. However, the fundamentals supporting our investment thesis remain intact, led by BCPC's leadership in niche markets and long history of consistent execution. We believe the company's strong competitive position and the robust demand environment will strengthen its market share over the long term.
Balchem Corp. (BCPC) develops specialty ingredients for the nutrition, food, and healthcare markets. The stock underperformed despite another quarter of solid financial results as investors focused on the potential for higher costs associated with the war in the Gulf. While first quarter sales increased 8%, management's elevated expectations left little room for upside despite continued strong execution. The fundamentals supporting our investment thesis remain intact, led by BCPC's leadership in niche markets and long history of consistent execution.
Balchem Corp. (BCPC) continues to demonstrate a durable business model with steady growth across its segments. The company is well-aligned with 'better-for-you' consumer trends, which has supported consistent earnings growth, with net income increasing nearly 17%. In a more uncertain market, investors are drawn to BCPC's ability to compound earnings with relatively low volatility, making it an attractive holding. The quarter highlighted the resilience of its operations and the favorable mix contributing to its performance.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||


